EUVIMEDOpdag EUVIMED
Crossref

Safflower Polysaccharides Target FXR to Regulate Intestinal Flora and Metabolic Disorders, Affecting FGFR4 / FGF15 to Improve Alcoholic Liver Fibrosis in Mice

Yuanchuang Wang, Zijun Zhao, Qingqing Li, Lishang Dai, Kaiyue Zhang, Yating Lu, Mengwei Jia, Zilin Song, Min Liu, Shenghui Chu iD

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70280 ↗

At a glance

Journal article in Phytotherapy Research, 2026. Written by Yuanchuang Wang and 9 co-authors. Institution: Pharmacy College of Shihezi University/Key Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, Shihezi University, …. Major MEDLINE topics: Fibroblast Growth Factors, Receptors, Cytoplasmic and Nuclear, Gastrointestinal Microbiome, Polysaccharides. Cited 2 times so far (Crossref); 44 references. Funded by: The National Natural Science Foundation of China, Guiding Science and Technology Program of XPCC, The Central Government Guides Local Funds of XPCC.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Chronic alcohol consumption disrupts gut microbiota and metabolic processes, leading to the transfer of microbial toxins from the intestines to the liver and accelerating the progression of alcoholic liver fibrosis (ALF). However, no effective drugs currently exist to treat ALF. Safflower polysaccharide (SPS), a natural compound extracted from safflower, has garnered significant attention in recent years for its potential clinical applications in treating liver‐related diseases. However, the efficacy of SPS in improving ALF and its underlying mechanisms remain unclear. Research indicates that SPS alleviates liver injury in ALF mice by modulating inflammation and fibrosis mechanisms through the gut‐liver axis and inhibiting hepatic stellate cell activation. SPS promotes the proliferation of beneficial bacteria, improves gut microbiota composition—including Lactobacillus and Bifidobacterium—and alters bile acid pool composition and its metabolites. Notably, the protective effect of SPS in ALF mice is attenuated by FXR inhibition. In vitro experiments confirmed that SPS effectively activates the FXR/FGFR4/FGF15 signaling pathway, counteracting the inhibitory effects of alcohol or specific bile acids on FXR activity. Immunofluorescence and Western blot analyses further confirmed that SPS enhances FXR activity by promoting its expression. These findings reveal a dual mechanism of action for SPS through regulating gut microbiota and bile acid metabolism, providing a theoretical basis for FXR‐targeted therapy in ALF and suggesting that the FXR/FGFR4/FGF15 pathway may represent a potential mechanism of action.

Subjects

MeSH terms (MEDLINE)

Fibroblast Growth FactorsReceptors, Cytoplasmic and NuclearGastrointestinal MicrobiomePolysaccharidesReceptor, Fibroblast Growth Factor, Type 4AnimalsReceptor, Farnesoid X-ActivatedMiceMaleMice, Inbred C57BLBile Acids and SaltsSignal TransductionLiverHepatic Stellate CellsLiver Diseases, Alcoholic

Author keywords

FXR/FGFR4/FGF15 interaction pathwayalcoholic liver fibrosisbile acid metabolismfarnesoid X receptorgut microbiota

Substances

Fibroblast Growth FactorsReceptors, Cytoplasmic and NuclearReceptor, Farnesoid X-Activatedfibroblast growth factor 15, mousePolysaccharidesReceptor, Fibroblast Growth Factor, Type 4Bile Acids and Salts

Authors and institutions

  • Pharmacy College of Shihezi University/Key Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, Shihezi University, Shihezi, China.
  • School of Traditional Chinese Medicine, Wenzhou Medical University, Wenzhou, People's Republic of China.

ORCID profiles: Shenghui Chu

Funding

  • The National Natural Science Foundation of China
  • Guiding Science and Technology Program of XPCC
  • The Central Government Guides Local Funds of XPCC
  • Shihezi University International Science and Technology Cooperation Promotion Program Project
  • Shihezi University Science and Technology Program System - National Natural Science Foundation General Project for Cultivation
  • Tianchi Academic Elite Leader Project, Corps Talented Youth program, Xinjiang safflower industry development fund
  • National Natural Science Foundation of China

Cite

APA

Wang, Y., Zhao, Z., Li, Q., Dai, L., Zhang, K., Lu, Y., Jia, M., Song, Z., Liu, M., & Chu, S. (2026). Safflower Polysaccharides Target FXR to Regulate Intestinal Flora and Metabolic Disorders, Affecting FGFR4 / FGF15 to Improve Alcoholic Liver Fibrosis in Mice. Phytotherapy Research. https://doi.org/10.1002/ptr.70280

Vancouver

Wang Y, Zhao Z, Li Q, Dai L, Zhang K, Lu Y, et al. Safflower Polysaccharides Target FXR to Regulate Intestinal Flora and Metabolic Disorders, Affecting FGFR4 / FGF15 to Improve Alcoholic Liver Fibrosis in Mice. Phytotherapy Research. 2026. doi:10.1002/ptr.70280

BibTeX
@article{Wang2026,
  author = {Wang, Yuanchuang and Zhao, Zijun and Li, Qingqing and Dai, Lishang and Zhang, Kaiyue and Lu, Yating and Jia, Mengwei and Song, Zilin and Liu, Min and Chu, Shenghui},
  title = {Safflower Polysaccharides Target FXR to Regulate Intestinal Flora and Metabolic Disorders, Affecting FGFR4 / FGF15 to Improve Alcoholic Liver Fibrosis in Mice},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70280}
}
Start for free →